Introduction {#S1}
============

The Guidelines of the European Hernia Society state, based on evidence level 1 A, that operation techniques using mesh result in fewer recurrences than techniques, which do not use mesh ([@B1]). Although mesh repair appears to reduce the likelihood of chronic groin pain rather than increase it ([@B1]), mesh can cause considerable pain and stiffness around the groin and affect physical functioning ([@B2]). This has led to various types of mesh being engineered, with a growing interest in lighter weight polypropylene (PP) meshes ([@B2]), absorbable meshes ([@B3]), and biological meshes. For open inguinal hernia repair the use of light-weight PP meshes was not associated with an increased risk of hernia recurrence. Light-weight PP meshes reduce the incidence of chronic groin pain as well as the risk of developing other groin symptoms ([@B4]). To avoid complications, the use of absorbable meshes -- such as those made of lactic acid polymer or lactic and glycolic acid copolymers -- has been proposed. This exposes the patient to inevitable hernia recurrence because the inflammatory response, through a hydrolytic reaction, completely digests the implanted prosthetic material ([@B3], [@B5]).

Another potential alternative to the synthetic meshes is biological meshes which, unlike absorbable meshes, are not completely degraded; instead, these induce a remodeling process, i.e., the biological mesh is incorporated into the host through the reproduction of new site-specific tissue. The clinical experiences gained with biological meshes for repair of inguinal hernias are presented below.

Materials and Methods {#S2}
=====================

A literature search of the Medline database was performed using the PubMed search engine. The following key words were used: Biological mesh; inguinal hernia OR Groin hernia AND Biological mesh OR Biomesh OR Biological. 2,277 citations were found. After checking the title and abstracts, there remained seven prospective randomized trials (RCTs) ([@B5]--[@B11]). In one of these seven RCTs (Table [1](#T1){ref-type="table"}), the results were reported for a smaller sample size ([@B6]) from the entire study ([@B5]) at an earlier follow-up time point. For two RCTs, only an abstract is available ([@B8], [@B9]). Recently, two meta-analyses were also published reporting on three and four RCTs, respectively ([@B12], [@B13]). Furthermore, there are five retrospective case series available ([@B14]--[@B18]), in which biological meshes had been used to repair inguinal hernias and the corresponding follow-up results reported (Table [2](#T2){ref-type="table"}). These are also described below.

###### 

**Characteristics and outcomes of RCTs on inguinal hernia repair with the use of biologic vs. polypropylene mesh**.

  Reference               Study design                                                  Patients characteristic                       Mesh material                                              Intervention details                           Follow-up                 Outcome                                                                                                                                                                     Conflict of interest               LoE
  ----------------------- ------------------------------------------------------------- --------------------------------------------- ---------------------------------------------------------- ---------------------------------------------- ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- -----
  ([@B8]) Abstract only   Prospective blinded randomized trial                          *n* = 140 primary inguinal hernias            Collagen mesh vs. polypropylene                            Open procedures                                12 months                 One recurrence in each group                                                                                                                                                NR                                 1b
  ([@B6])                 Prospective double-blinded randomized trial                   *n* = 20 primary inguinal hernias             SIS vs. polypropylene                                      Lichtenstein in general or spinal anesthesia   6 months                  No recurrence, no wound infection, no post-hemioplasty acute and chronic pain/discomfort, parenteral/oral analgesic consumption were lower in surgisis group                NR                                 1b
  ([@B7])                 Prospective randomized trial                                  *n* = 45 male patients with inguinal hernia   SIS vs. polypropylene vs. polylactic and polypropylene     Lichtenstein in local anesthesia               Mean: 12 months (1--16)   No recurrence, postoperative pain lower with SIS, full recovery shorter with SIS                                                                                            NR                                 1b
  ([@B9]) Abstract only   Prospective blinded randomized trial                          *n* = 201                                     Porcine dermal collagen vs. polypropylene                  Open procedure                                 24 months                 No difference in recurrence rate, collagen repairs had improved pain scores                                                                                                 NR                                 1b
  ([@B5])                 Double-blinded RCT                                            *n* = 70 primary inguinal hernia              SIS vs. polypropylene                                      Lichtenstein in general or spinal anesthesia   36 months                 One recurrence in the PP group; significant lower pain degree for the SIS group                                                                                             NR                                 1b
  ([@B10])                Prospective, double-blinded, single-center randomized trial   *n* = 100                                     Biodesign Inguinal Hernia Matrix (IHM) vs. polypropylene   Lichtenstein in local anesthesia               12 months                 Three recurrences in the IHM group vs. 0 in the polypropylene group (*p* = 0.11). Persistent pain trended higher in the polypropylene group                                 Grant from producer of IHM         1b
  ([@B11])                Prospective, double-blinded, multicenter randomized trial     *n* = 172                                     Strattice vs. Ultrapro                                     Lichtenstein in local or general anesthesia    3 months                  No recurrence, no wound complication, impairment caused by the hernia decreased significantly in both groups, less postoperative pain days 1 and 3 in the Strattice group   Grant form producer of Strattice   1b

###### 

**Characteristics and outcomes of studies reporting on inguinal hernia repair with the use of biologic mesh**.

  Reference   Study design                Patients characteristic                                              Mesh material               Intervention details                                                                                         Follow-up                   Outcome                                                   Conflict of interest   LoE
  ----------- --------------------------- -------------------------------------------------------------------- --------------------------- ------------------------------------------------------------------------------------------------------------ --------------------------- --------------------------------------------------------- ---------------------- -----
  ([@B14])    Retrospective case series   *n* = 137 male patients *n* = 16 emergency cases                     Porcine dermis (Zenoderm)   Modified Notaras-technique                                                                                   Mean: 48 months             Two recurrences (1.25%)                                   NR                     4
  ([@B18])    Retrospective case series   *n* = 15 potentially or grossly contaminated field                   SIS                         Laparoscopic TAPP                                                                                            Median: 19 months (1--30)   No recurrence                                             NR                     4
  ([@B17])    Retrospective case series   *n* = 10 sports hernia. Professional or amateur athletes             SIS                         TEP; 7 cm × 10 cm mesh size, fixation with five tacks (Protack), one patient had only fibrin glue fixation   12 months                   Nine improved, one not                                    NR                     4
  ([@B15])    Retrospective case series   *n* = 38 patients with 45 primary and 6 recurrent inguinal hernias   SIS                         TEP; 7 cm × 10 cm mesh size, fibrin glue fixation                                                            Mean: 13 months (1--30)     One recurrence (2%), three patients chronic pain (7.9%)   NR                     4
  ([@B16])    Retrospective case series   *n* = 11                                                             SIS                         TAPP; Fibrin glue fixation                                                                                   Mean: 14.5 ± 1 month        One recurrence                                            NR                     4

Results {#S3}
=======

In a prospective randomized double-blind trial ([@B5], [@B6]), Lichtenstein's inguinal hernia repair was compared using a PP or a small intestine submucosa (SIS) mesh. Seventy male patients underwent Lichtenstein's hernioplasty, with 35 patients in the SIS group and 35 patients in the PP group. At 3 years after surgery, there were two deaths (5.7%) in the PP group and one death (2.9%) in the SIS group (NS). Only one recurrence (2.9%) was seen in the PP group (NS). Although a significant decrease in the postsurgical pain incidence was never observed among patients in the SIS group, a significantly lower degree of pain was detected at rest and on coughing at 1, 3, and 6 months and on movement at 1, 3, and 6 months and 1, 2, and 3 years. A significant decrease in the postsurgical incidence and degree of discomfort when coughing and moving were observed among patients in the SIS group at 3 and 6 months and at 1, 2, and 3 years after surgery. The authors concluded that SIS hernioplasty seems to be a safe and effective procedure.

In a prospective RCT ([@B7]), Lichtenstein inguinal hernioplasty was performed in local anesthesia, using prolene (PP) or vypro (polylactin and PP) or SIS. The median follow-up was 12 months, with a range of 1--16 months. No recurrent hernias were observed. Postoperative pain (visual analog scale) and discomfort were lower in patients with SIS. There was a tendency toward a higher incidence of pain and discomfort in the vypro and prolene group.

In an abstract as interim report, Macklin et al. ([@B8]) have treated 140 patients in a prospective RCT receiving either PP or collagen mesh. Postoperatively, there was an increase in hematoma in the PP group (*p* = 0.048). Infection and inflammation were similar postoperatively and at 3 months. There was one recurrent hernia in each group in 1 year.

Initial results showed that collagen mesh is an effective method of providing tissue repair in primary inguinal hernia.

In another abstract, Ridgway et al. ([@B9]) reported on a blinded randomized controlled trial comparing porcine dermal collagen with PP for primary inguinal hernia repair in 201 patients. Recurrence, inflammation, infection, and hematoma rates were comparable at all time intervals. Collagen repairs had improved pain scores at 2 years. The authors concluded that inguinal hernia repair using modified porcine dermal collagen can be performed successfully.

In another prospective, randomized, double-blinded, single-center study ([@B10]), the use of a Biodesign Inguinal Hernia Matrix (IHM) vs. a PP mesh for Lichtenstein operation was compared for 100 patients. The follow-up period was 1 year. Three recurrences were observed in the IHM group and none in the PP group (*p* = 0.11). There was a higher tendency toward persistent pain in the PP group (6 vs. 4%).

Likewise, in a prospective randomized, double-blinded multicenter study ([@B11]) that compared the use of Strattice vs. Ultrapro for Lichtenstein operation in 100 patients, no differences were observed in the wound complication rate after 3 months. No recurrences occurred in any of the two groups, nor any difference was seen in postoperative pain after 3 months.

On pooling, the results of the three ([@B5], [@B7], [@B10]) aforementioned RCTs, each of which used small intestinal submucosa (SIS), no difference was found in the recurrence and pain rate after 1 year ([@B12]). Only the discomfort rate was lower in the SIS group, but the seroma rate was higher. Likewise, these findings are confirmed in the meta-analysis of four ([@B5], [@B7], [@B10], [@B11]) RCTs ([@B13]).

In a retrospective case series Holl-Allen ([@B14]) published the results of 137 consecutive unselected male patients with inguinal hernias treated with Zenoderm as the repair material after a mean follow-up of 48 months. There have been two indirect recurrences after 11 and 14 months, representing a low recurrence rate of 1.25%.

In three retrospective case series ([@B15]--[@B18]) with 10--38 patients, inguinal hernias were repaired in an endoscopic technique (TEP, TAPP) with SIS. During a mean follow-up period of 12--14.5 months, a recurrence rate of 2 and 9.1% was observed, respectively ([@B15], [@B16]). No improvement in symptoms was seen in one patient with a sports hernia following TEP operation with SIS ([@B17]). In another study the biological meshes (SIS) were used successfully even in a potentially contaminated setting, i.e., with incarcerated/strangulated bowel within the hernia or coincident with a laparoscopic cholecystectomy/colectomy as well as in a grossly contaminated field (i.e., gross pus or fecal spillage) ([@B18]).

Discussion {#S4}
==========

Inguinal hernias can be repaired with biological meshes, and with a reasonable recurrence rate. This applies for a period of 3 years for the Lichtenstein operation and of 1 year for the endoscopic TEP and TAPP techniques. As such, biological meshes can be used as an alternative in a potentially contaminated field for incarcerated inguinal hernia or coincident with a laparoscopic cholecystectomy or colectomy as well as in a setting grossly contaminated with pus or fecal spillage ([@B18]). However, this was a retrospective case series rather than a RCT. The RCTs identified demonstrated the equivalence of a biological mesh and the PP mesh in terms of the recurrence rate as well as reduced pain at rest, on coughing or on movement. Because of the very small sample size, the equivalence of biological meshes and synthetic meshes with regard to recurrence rate and reduced pain must be verified in further studies. Besides, in none of the studies were the higher costs incurred for the biological meshes analyzed. Since the biological meshes do not have any major advantages over the synthetic meshes with respect to the most important assessment criteria, at present they can only be recommended for situations involving a contaminated surgical field.
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Aim {#S7}
===

The BioMesh Study Group has set itself the task of identifying how best to use biological meshes for the various indications. The first step toward achieving that goal is to compile systematic reviews of the different indications on the basis of the existing literature. The available literature sources will be evaluated in accordance with the Oxford Centre for Evidence-based Medicine-Levels of Evidence (March 2009). Next, based on the review findings corresponding Statements and Recommendations are to be formulated in a Consensus Conference for the use of biological meshes for the different indications. The findings of the Consensus Conference are then to be summarized for a joint publication. This present publication is part of the project undertaken by the BioMesh Study Group.
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